Integrated continuous biomass estimation in fixed-bed bioreactors
Novel approach allows for real-time measurement of cell density in fixed-bed bioreactors
Learn moreDiscover our publications
Novel approach allows for real-time measurement of cell density in fixed-bed bioreactors
Learn moreOur Product Manager Clément Dumont explains how an innovative fixed-bed small-scale parallel system will revolutionize process design & optimization steps resulting in an increased production capacity & quality.
DownloadAddressing biomanufacturing challenges through flexible platform design for both adherent & suspension cell lines
Learn moreDecouple process from technology for gene therapy manufacture
Learn moreShake flask process transferred in a scale-X hydro fixed-bed bioreactor for Adenovirus production with HEK293 cells adapted to suspension.
Learn moreProcess optimization and scale-up from static flask to scale-X bioreactor with 30 m² cell growth surface.
Learn moreIntensified and automated dual platform for increased flexibility in viral vector manufacture
Learn moreDirect process reproduction from multi-layer bioreactor and roller bottles for four vaccine antigens using three different cell lines (CEF, WI-38 and Vero cells)
Learn moreUnivercells Technologies provides reliable service solutions and quality support & maintenance to help you maintain performance and maximum safety of the equipment.
DownloadThe scale-X hydro bioreactor is a small-scale, single-use, structured fixed-bed bioreactor enabling direct process transfer from existing processing technology for rapid proof of concept within a reduced footprint.
DownloadCase study comparing adherent Vero cell growth on microcarriers and intensified, fixed-bed scale-X bioreactors hydro (2.4 m²) and carbo (10-30 m²). Results demonstrate the scale-X bioreactors as a suitable alternative to traditional technologies.
Learn moreThe NevoLine™ Upstream system is a high-performance and automated platform for commercial virus manufacturing. It integrates all process steps from inoculation to midstream processing to deliver a ready for downstream bulk.
DownloadThe scale-X™ bioreactor range and the NevoLine™ platform: integrated and automated solutions for an intensified AAV and Lentiviral vectors manufacturing.
DownloadPoster illustrates the key features, benefits and applications of the NevoLine concept with the emphasis on the first implementation of this approach – The NevoLine platform for trivalent polio vaccine (sIPV).
DownloadProof of concept for scalable adherent cell growth and adenovirus production
Learn moreThe scale-X™ carbo system is a bench-scale automated cell culture system for expression and concentration of viral drug substance, suited for rapid process development and cost-effective clinical production.
DownloadThe NevoLine sIPV platform was designed and developed by Univercells as part of a $12M Grand Challenges grant awarded by the Bill & Melinda Gates Foundation. This proof of concept was developed to deliver affordable inactivated polio vaccine (sIPV) in a low footprint.
DownloadPoster presents the NevoLine concept to deliver affordable vaccine doses based on sIPV polio vaccine case study.
Download